GIOVANNELLI, Simona
 Distribuzione geografica
Continente #
EU - Europa 1.754
NA - Nord America 1.722
AS - Asia 314
AF - Africa 7
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.804
Nazione #
US - Stati Uniti d'America 1.713
IT - Italia 873
IE - Irlanda 248
GB - Regno Unito 245
SE - Svezia 138
CN - Cina 121
DE - Germania 85
UA - Ucraina 62
SG - Singapore 50
HK - Hong Kong 43
FI - Finlandia 28
TR - Turchia 28
IN - India 23
BG - Bulgaria 22
FR - Francia 16
VN - Vietnam 16
LT - Lituania 11
ID - Indonesia 8
IR - Iran 7
MY - Malesia 6
MX - Messico 5
AL - Albania 4
CA - Canada 4
CH - Svizzera 4
IQ - Iraq 4
KE - Kenya 4
ES - Italia 3
RU - Federazione Russa 3
TW - Taiwan 3
BE - Belgio 2
BO - Bolivia 2
EG - Egitto 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
BR - Brasile 1
BY - Bielorussia 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
EU - Europa 1
HU - Ungheria 1
JP - Giappone 1
LB - Libano 1
ME - Montenegro 1
MZ - Mozambico 1
NO - Norvegia 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 3.804
Città #
Dublin 248
Chandler 201
Southend 193
Fairfield 184
Woodbridge 141
Dearborn 134
Ashburn 126
Jacksonville 114
Nyköping 98
Ann Arbor 84
Houston 83
Seattle 69
Milan 67
Rome 66
Wilmington 64
Cambridge 62
New York 56
Beijing 46
Hong Kong 42
Singapore 34
Naples 27
Izmir 22
Princeton 22
Eugene 21
Sofia 21
Bari 19
San Diego 19
Modena 18
Turin 18
Helsinki 17
Palermo 17
Bologna 16
Dong Ket 16
Shanghai 11
Vicenza 11
Florence 10
Genoa 10
Bremen 9
Catania 9
Jakarta 8
London 8
Perugia 8
Pisa 8
Venice 8
Fremont 7
Padova 7
San Mateo 7
Ancona 6
Brescia 6
Cagliari 6
Monte Porzio 6
Norwalk 6
Phoenix 6
Redwood City 6
Reggio Emilia 6
Des Moines 5
Lecce 5
Sassari 5
Augusta 4
Bergamo 4
Bitritto 4
Boardman 4
Falls Church 4
Gallarate 4
Munich 4
San Giovanni Valdarno 4
Tirana 4
Bangalore 3
Cremona 3
Dallas 3
Dietikon 3
Furtei 3
Guarene 3
Hefei 3
Kunming 3
Madrid 3
Martano 3
Matera 3
Mexicali 3
Nairobi 3
Nanchang 3
Noicattaro 3
Penne 3
Santa Maria Imbaro 3
Senago 3
Taipei 3
Verona 3
Albignasego 2
Albizzate 2
Anguillara Veneta 2
Arcore 2
Ardabil 2
Arezzo 2
Avellino 2
Bacoli 2
Bagnoli del Trigno 2
Berlin 2
Bra 2
Brooklyn 2
Calcinaia 2
Totale 2.671
Nome #
VALORE PROGNOSTICO E PREDITTIVO DI p53 NEL CARCINOMA MAMMARIO TRATTATO CON CHEMIOTERAPIA NEOADIUVANTE 682
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVO 301
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 283
Letrozole Versus Letrozole Plus Lapatinib (GW572016) in Hormone-Sensitive, HER2-Negative Operable Breast Cancer: A Double-Blind, Randomized Phase II Study with Biomarker Evaluation (EGF109077-LAP107692/LETLOB) 240
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer. 220
MODULAZIONE DELL’ESPRESSIONE DI BIOMARCATORI E PROGNOSI IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO OPERABILE SOTTOPOSTE A CHEMIOTERAPIA PREOPERATORIA 201
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy. 192
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis 185
Preoperative chemotherapy plus lapatinib or trastuzumab or both in Her2 positive operable breast cancer. EGF109085-LAP106988/CHERLOB Trial. 171
A prognostic model based on nodal status and Ki 67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy 159
Preliminary safety data of preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer 143
Primary systemic therapy for operable breast cancer: a review of clinical trials and perspectives 128
IMPROVED SURVIVAL AFTER RADIOTHERAPY FOR BRAIN METASTASES IN PATIENTS WITH HER2 POSITIVE BREAST TUMORS 118
Biomarker expression and survival after primary chemotherapy for breast cancer. 112
LAPATINIB IN ASSOCIAZIONE A CAPECITABINA IN PAZIENTI CON CARCINOMA MAMMARIO METASTTICO HER2 POSITIVO IN PROGRESSIONE DOPO TERAPIA CON TRASTUZUMAB 106
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVE: ANALISI PRELIMINARE DELLE TOSSICITA’ 103
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 103
CARCINOMI MAMMARI HER2 POSITIVI: CASISTICA DI MODENA 102
Operable Breast Cancer: preliminary results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarkers evaluation 98
VALUTAZIONE DEL RISCHIO DI TOSSICITA’ CARDIACA DI TRASTUZUMAB IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO IN TRATTAMENTO ADIUVANTE 94
CHEMOTHERAPY-INDUCED MODULATION OF BIOMARKERS EXPRESSION IN PRIMARY BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY 86
Totale 3.827
Categoria #
all - tutte 10.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.999


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020504 0 0 0 36 81 102 111 52 52 23 31 16
2020/2021432 56 20 30 31 44 22 52 42 38 28 40 29
2021/2022381 8 49 53 13 7 23 20 9 50 16 88 45
2022/2023866 81 76 29 64 52 67 13 48 310 30 59 37
2023/2024766 36 45 44 48 82 68 53 111 38 69 88 84
2024/2025228 57 65 45 61 0 0 0 0 0 0 0 0
Totale 3.827